Sangamo BioSciences acquires Gendaq, valued at around $30m (£21m).

Gendaq advised by Olswang (Tina Cowen, Howard Palmer) and Wilson Sonsini Goodrich & Rosati (Steve Camahort) on the US side. Sangamo advised by Brobeck Hale and Dorr and Brobeck Phleger & Harrison (John Larsen) on US issues.